Key drivers include increasing maternal age, technological innovations, heightened awareness, and a strong healthcare ...

Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The "Prenatal and Newborn Genetic Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive ...

Natera Inc. is conducting a study titled ‘EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND).’ The study aims to develop and validate a single-gene Non-Invasive Prenatal ...

Considering pregnancy later in life? Find out what “advanced maternal age” really means, the risks to consider and how women ...

Early detection saves lives. From cancer and heart disease to reproductive health, learn the essential screenings every woman ...

Genetic testing during pregnancy helps spot a baby’s risk of inherited disorders or chromosomal abnormalities. This article examines its pros and cons straightforwardly and engagingly. Learn what ...

Natera, Inc. , a global leader in cell-free DNA (cfDNA) and precision medicine, today announced it will expand its Fetal Focus test to cover 20 genes, marking a major advancement in single-gene ...

Detailed price information for Myriad Genetics Inc (MYGN-Q) from The Globe and Mail including charting and trades.

Myriad Genetics (($MYGN)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for Myriad Genetics ...

Autism Spectrum Disorder is a complex condition with rising global prevalence. Research indicates it stems from a blend of ...

"Raffles Medical Group is delighted to partner with Gene Solutions to bring cutting-edge clinical trials to patients in ...

Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today ...